Results 161 to 170 of about 791,464 (334)

Neoadjuvant therapy in skin cancer: current evidence and future perspectives

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary The development of immune checkpoint inhibitors and targeted therapies has fundamentally changed the treatment of cutaneous malignancies, especially in squamous cell carcinoma, melanoma, and Merkel cell carcinoma. The latest neoadjuvant approaches have shown promising results in locally advanced stages.
Lea Daniello   +2 more
wiley   +1 more source

Evidence‐ and consensus‐based guideline on lichen sclerosus

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary The German‐language, consensus‐ and evidence‐based S3 guideline on lichen sclerosus (LS) was developed based on the European “EuroGuiDerm Guideline on lichen sclerosus” under the leadership of the German Dermatological Society (DDG) and the German Society for Gynecology and Obstetrics (DGGG).
Gudula Kirtschig   +25 more
wiley   +1 more source

The role of 18F-FDG PET/CT in primary cutaneous lymphoma: an educational review. [PDF]

open access: yesAnn Nucl Med, 2023
McDonald EO   +6 more
europepmc   +1 more source

Dermoscopy in the diagnosis of cutaneous lymphoma (Review). [PDF]

open access: yesExp Ther Med, 2022
Ungureanu L   +4 more
europepmc   +1 more source

Cutaneous Metastasis in Patient With Relapse Case of Primary Testicular Lymphoma

open access: yesClinical Case Reports
Non‐Hodgkin's lymphoma originates in the lymphatic system, specifically affecting B or T lymphocytes. Non‐Hodgkin's lymphoma of the testis is highly aggressive extranodal lymphoma originating from the testicles, constituting 1%–2% of all non‐Hodgkin's ...
Mahesh Mathur   +5 more
doaj   +1 more source

The Role of SAMHD1 in Viral Resistance and Transduction Efficiency Challenges in Pediatric Hematological Malignancies: Mechanistic Insights and Clinical Perspectives

open access: yesEuropean Journal of Haematology, EarlyView.
SAMHD1 regulates intracellular dNTP pools, influencing lentiviral transduction, gene therapy efficiency, and disease progression in pediatric hematological malignancies. Integrated bioinformatics and targeted strategies, including CRISPR and pharmacological inhibition, highlight its therapeutic potential.
Waseem Alzamzami
wiley   +1 more source

Cutaneous Hodgkin’s lymphoma

open access: yesSouth Asian Journal of Cancer, 2017
Asawari Anant Ambekar   +1 more
openaire   +3 more sources

Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma following heart transplantation [PDF]

open access: yes, 2017
Post-transplantation cutaneous lymphoproliferative diseases (PTCLD) are rare, with 29 cases have so far been reported in the literature—only 4 cases underwent cardiac transplantation.
Mandegar, M.H.   +2 more
core  

Management of Primary Refractory Diffuse Large B‐Cell Lymphoma in Patients Unsuitable for CAR T‐Cell Therapy

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Primary refractory Diffuse Large B‐Cell Lymphoma is associated with poor outcomes and limited responsiveness to conventional salvage therapies. Although CAR T‐cell therapy represents the standard of care in this setting, a substantial proportion of patients cannot receive it despite meeting disease‐related criteria. In this review, “unsuitable”
Santino Caserta   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy